| [1] |
Marques⁃Mejias A, Bartha I, Ciaccio CE, et al. Skin as the target for allergy prevention and treatment[J]. Ann Allergy Asthma Immunol, 2024,133(2):133⁃143. DOI: 10.1016/j.anai.2023.12. 030.
|
| [2] |
Dong D, Ni Q, Wang C, et al. Effects of intestinal colonization by Clostridium difficile and Staphylococcus aureus on microbiota diversity in healthy individuals in China[J]. BMC Infect Dis, 2018,18(1):207. DOI: 10.1186/s12879⁃018⁃3111⁃z.
|
| [3] |
Mohammad S, Karim MR, Iqbal S, et al. Atopic dermatitis: pathophysiology, microbiota, and metabolome ⁃ a comprehensive review[J]. Microbiol Res, 2024,281:127595. DOI: 10.1016/j.micres.2023.127595.
|
| [4] |
Wrześniewska M, Wołoszczak J, Świrkosz G, et al. The role of the microbiota in the pathogenesis and treatment of atopic dermatitis⁃a literature review[J]. Int J Mol Sci, 2024,25(12):6539. DOI: 10.3390/ijms25126539.
|
| [5] |
Landemaine L, Da Costa G, Fissier E, et al. Staphylococcus epidermidis isolates from atopic or healthy skin have opposite effect on skin cells: potential implication of the AHR pathway modulation[J]. Front Immunol, 2023,14:1098160. DOI: 10.3389/ fimmu.2023.1098160.
|
| [6] |
李亨, 段瑞生. 小檗碱在自身免疫性疾病治疗中的研究进展[J]. 国际免疫学杂志, 2013,36(4):265⁃267,275.
|
| [7] |
Lu Q, Fu Y, Li H. Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders[J]. Pharmacol Rep, 2022,74(2):297⁃309. DOI: 10.1007/s43440⁃021⁃00348⁃7.
|
| [8] |
Zhou H, Wang W, Cai L, et al. Potentiation and mechanism of berberine as an antibiotic adjuvant against multidrug⁃resistant bacteria[J]. Infect Drug Resist, 2023,16:7313⁃7326. DOI: 10.2147/IDR.S431256.
|
| [9] |
Song L, Zhang W, Tang SY, et al. Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state⁃of⁃the⁃art drug delivery systems[J]. Biomed Pharmacother, 2024,170:116039. DOI: 10.1016/j.biopha.2023.116039.
|
| [10] |
Haftcheshmeh SM, Abedi M, Mashayekhi K, et al. Berberine as a natural modulator of inflammatory signaling pathways in the immune system: focus on NF⁃κB, JAK/STAT, and MAPK signaling pathways[J]. Phytother Res, 2022,36(3):1216⁃1230. DOI: 10.1002/ptr.7407.
|
| [11] |
林洁, 李维, 曾山, 等. 指纹图谱结合网络药理学及实验验证的黄连膏治疗特应性皮炎质量标志物(Q⁃marker)预测[J]. 中药与临床, 2023,14(6):55⁃64. DOI: 10.3969/j.issn.1674⁃926X. 2023.06.010.
|
| [12] |
Jin J, Hua G, Meng Z, et al. Antibacterial mechanisms of berberine and reasons for little resistance of bacteria[J]. Chin Herb Med, 2010,3(1):27⁃35.
|
| [13] |
Xia S, Ma L, Wang G, et al. In vitro antimicrobial activity and the mechanism of berberine against methicillin⁃resistant Staphylococcus aureus isolated from bloodstream infection patients[J]. Infect Drug Resist, 2022,15:1933⁃1944. DOI: 10. 2147/IDR.S357077.
|
| [14] |
Sun H, Ansari MF, Fang B, et al. Natural berberine⁃hybridized benzimidazoles as novel unique bactericides against Staphylococcus aureus[J]. J Agric Food Chem, 2021,69(28):7831⁃7840. DOI: 10.1021/acs.jafc.1c02545.
|
| [15] |
牛蔚露, 陈恋恋, 冯敏, 等. 三种中药单体体外对特应性皮炎优势菌群活性的影响[J]. 时珍国医国药, 2022,33(2):345⁃348. DOI: 10.3969/j.issn.1008⁃0805.2022.02.23.
|